Nordwest Clinic (Krankenhaus)
Nordwest Clinic (Krankenhaus)
Germany, Frankfurt am Main
Elke Jaeger
41 years of experience
Clinic is certified :
Burkitt's lymphoma treatment cost in Germany generally includes essential diagnostics like a bone marrow puncture with cytogenetic analysis ranging from $1,100 to $2,100. Primary treatment regimens often involve chemotherapy which runs from $1,200 to $4,000, with complex cases requiring bone marrow transplantation. Total expenses depend on the protocol, hospital stay duration, and disease stage. Major medical centers for this treatment are located in Hamburg, Frankfurt am Main, and Dusseldorf.
Typical Burkitt"s Lymphoma Treatment Costs in Germany
Bookimed Expert Insight: Patients requiring advanced protocols benefit from Germany's university-affiliated centers. Asklepios Hospital Barmbek is ranked as a top facility for international patients by MTQA. For aggressive cases, Nordwest Clinic offers innovative anticancer vaccines and targeted therapies under Professor Elke Jaeger. High-volume centers like Asklepios St. Georg, performing over 3,000 transplants, provide better value for complex bone marrow procedures.
| Germany | Turkey | Austria | |
| Radiation therapy for colorectal cancer | from $20,000 | from $7,000 | from $12,000 |
| Chemotherapy for breast cancer | from $4,500 | from $1,200 | from $15,000 |
| Chemotherapy | from $1,164 | from $2,430 | from $2,500 |
| Bone marrow transplantation | from $180,000 | from $36,000 | from $140,000 |
| Autologous bone marrow transplantation | from $150,000 | from $31,500 | from $50,000 |
1,100+ treatments performed – Prof. Elke Jaeger is a top German oncologist specializing in Burkitt's lymphoma at Nordwest Clinic.
Dr. Fox specializes in Burkitt's lymphoma treatment, blending innovative therapies with extensive research on haemato-oncological diseases at Medical Center in Solingen.
Dr. Eckhart Weidmann leads the Hematology sector at Nordwest Clinic with over 36 years of experience of practice in treating blood disorders.
Head of the Bone Marrow Transplant Center at Essen University Hospital – specializes in oncohematology with a focus on Burkitt's lymphoma.
Burkitt lymphoma treatment in Germany must begin immediately, typically within 24 to 48 hours of diagnosis. This aggressive cancer can double in size daily. German oncology centers prioritize rapid hospitalization to bypass wait times and initiate life-saving chemotherapy protocols without any administrative delay.
Bookimed Expert Insight: German hematology departments like Nordwest Clinic operate as high-volume research hubs. Prof. Elke Jaeger and her team manage complex cases where protocol speed is vital. Our data shows these facilities provide specialized sectors for non-Hodgkin lymphoma. This ensures that molecular diagnostics and chemotherapy preparation happen simultaneously rather than sequentially.
Patient Consensus: Patients emphasize that this disease allows no time for a watch and wait approach. They note that while preparation like kidney stabilization is vital, administrative delays are not tolerated by German medical teams.
Standard first-line therapy for Burkitt lymphoma in Germany involves intensive, multi-agent chemotherapy regimens. Because this cancer grows rapidly, specialists initiate treatment as a medical emergency. Common protocols like CODOX-M/IVAC or Hyper-CVAD are frequently combined with immunotherapy using rituximab for CD20-positive cases.
Bookimed Expert Insight: German university hospitals like Dusseldorf or Essen often use pediatric-inspired intensive protocols for adult patients. These regimens are significantly more aggressive than standard lymphoma treatments but lead to higher recovery rates. Dr. Eckhart Weidmann at Nordwest Clinic manages these cases within specialized hematology sectors to ensure immediate, protocol-driven care.
Patient Consensus: Patients note that the first few days are intense due to constant lab tests and IV fluids. They emphasize the importance of starting therapy immediately after diagnosis to manage the rapid tumor growth safely.
Central nervous system prophylaxis is not legally mandatory in Germany. However, it is a standard medical requirement within clinical protocols for Burkitt lymphoma. German centers follow strict guidelines from the German Society for Hematology and Medical Oncology to prevent high relapse risks in the brain.
Bookimed Expert Insight: While German law allows patients to refuse treatment, specialized centers like Nordwest Clinic or University Hospital Dusseldorf rarely view prophylaxis as optional for Burkitt cases. Data shows these institutions treat over 45,000 inpatients annually and adhere to rigid, protocol-driven care. In Frankfurt, specialists like Dr. Eckhart Weidmann or Prof. Elke Jaeger with 30+ years of experience typically embed these steps directly into the primary chemotherapy schedule rather than treating them as separate add-ons. Patients should expect the protocol to be non-negotiable for achieving high survival rates in aggressive subtypes.
Patient Consensus: Patients note that while lumbar punctures for prophylaxis are uncomfortable, they are accepted as a necessary part of the cure. Most recommend asking about headache prevention techniques or Ommaya reservoirs if many procedures are planned.
Burkitt lymphoma success rates in Germany range between 70% and 90% for standard cases. Pediatric cure rates often exceed 95% due to specialized BFM protocols. Survival for adults typically falls between 70% and 85% when treated at accredited hematology centers like Nordwest Clinic.
Bookimed Expert Insight: Success in Germany stems from strict adherence to high-volume research protocols. Prof. Dr. Elke Jaeger at Nordwest Clinic specializes in innovative anticancer vaccines and targeted therapy. University hospitals like Dusseldorf manage 350,000 yearly cases and offer 69 specialized departments. These high patient volumes ensure doctors maintain the expertise needed to manage intensive chemotherapy risks effectively.
Patient Consensus: Speed of starting treatment matters more than anything else for this aggressive cancer. Patients emphasize that intensive inpatient care is necessary to manage side effects and monitor vitals closely.
Highly regarded German hospitals for Burkitt lymphoma include large university complexes and ESMO-certified centers specializing in intensive chemoimmunotherapy. Facilities like Nordwest Clinic and University Hospital Dusseldorf are recognized for advanced hematology sectors. They provide rapid diagnostics and inpatient supportive care for this aggressive condition.
Bookimed Expert Insight: Focus on clinics with integrated research institutes and high doctor-to-patient ratios. Nordwest Clinic, for instance, maintains 5 research institutes and nearly 300 doctors for its 28 departments. This concentration of expertise is vital for Burkitt lymphoma, which requires constant monitoring for tumor lysis syndrome during rapid treatment phases.
Patient Consensus: Patients emphasize that Burkitt lymphoma must be treated as a medical emergency. They recommend choosing a hospital that can start intensive chemotherapy immediately and has an onsite multidisciplinary tumor board to review complex pathology results.
International patients treating Burkitt lymphoma in Germany should plan for a stay ranging from 4 weeks to several months. This timeline accounts for intensive diagnostic staging and multiple chemotherapy cycles. High-risk cases requiring bone marrow transplantation may extend the necessary stay to 3 months.
Bookimed Expert Insight: German university hospitals like Dusseldorf or large complexes like Nordrhein-Westfalen handle over 145,000 patients annually. Because Burkitt lymphoma is highly aggressive, these high-volume centers prioritize immediate port placement and first-cycle monitoring. Data shows that staying within 15 minutes of the clinic is vital during the first 21 days due to rapid treatment responses.
Patient Consensus: Patients emphasize that the initial stay is much longer than a standard consultation. Most recommend budgeting at least 4 weeks early on to manage infection risks and observe how the body reacts to the first cycle before considering travel.